Secondary Acute Myeloid Leukemia — Trials

Secondary Acute Myeloid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

212 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 46
Recruiting: 21
Ph III recruiting: 0
Growth YoY: —
Industry share: 7%
Top sponsor: National Cancer Institute (NCI)
Termination share: 31.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (39)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07635485	VA Induction and Bridging Transplantation for Hypoplastic/Secondary AML	not yet recruiting	N/A	50	The First Affiliated Hospital of Soochow UniversityOTHER	1	Jun 9, 2026	clinicaltrials
NCT05554419	Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)	not yet recruiting	Phase 2	184	National Cancer Institute (NCI)NIH	0	Apr 13, 2026